GLP-1 and SGLT-2: Treatments Too Good to Ignore? Save
Dr. Peter Nash reviews several studies presented on GLP-1s at the 2025 ACR Convergence meeting in Chicago. He recommends for review abstracts: 0841, 0849, 1027, 2685, 0165, 0233 and 2658.
Dr. Peter Nash reviews several studies presented on GLP-1s at the 2025 ACR Convergence meeting in Chicago. He recommends for review abstracts: 0841, 0849, 1027, 2685, 0165, 0233 and 2658.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.